UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Explore effective wealth management for families to enhance your collective financial health and achieve shared financial goals.
19,417 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Set a weekly ritual to translate headlines into a smarter portfolio. This Thursday reads guide shows you how to pick ...
Meta Platforms stock has moved lower—about 17% over six months. This article breaks down what that decline means, how...
Tech giants swing on headlines. This guide unpacks why meta stock dropped then, how the rebound happened, and what in...
SharpLink Gaming Stock posted a $734 million full-year loss tied to its Ethereum holdings, signaling a new era of cry...
AscendEX ceased normal operations on July 1 as MiCA rules tightened, with withdrawal requests slowed or blocked. Zach...
Pi Network announces a major protocol upgrade and an AI-focused case study, setting the stage for potential moves aro...
Pressed for time but want real budgeting results? This guide shows how to set up a budget in 30 minutes using a simpl...
Alphabet stands at a crossroads: Sundar Pichai could pull in up to $692 million over three years, but half of that de...
A sharp look at how Rivian Automotive and Tesla earn money, where their revenue comes from, and what the trends mean ...
A major fund recently trimmed its Centrus Energy stake, sending ripples through the market. This article breaks down ...
A musician faces a voice setback, and a smart money plan follows. This guide translates that comeback into actionable...